Why physiology matters for coagulation
Giving a product is not enough if the physiology that limits clot formation is not corrected. Temperature, pH, calcium, and dilution should be assessed alongside every targeted replacement decision.
Key points
- Hypothermia, acidosis, low ionized calcium, and dilution each impair clot formation through different mechanisms.
- Blood products may not restore clot strength if the underlying physiology is not corrected in parallel.
- Correct physiology alongside targeted replacement and reassess both the VET pattern and the actual bleeding.
When to use this page
During perioperative or post-CPB bleeding, when reviewing whether physiologic factors may be limiting the response to blood products — before escalating product administration.
Why physiology limits product efficacy
Coagulation enzymes and platelets are temperature-sensitive, pH-sensitive, and calcium-dependent. When physiology is outside a functional range, products that appear appropriate may fail to improve clot formation in practice. Recognizing and correcting physiology is not a secondary concern — it is part of the same decision as targeted replacement.
Hypothermia
Coagulation is a series of enzymatic reactions. At lower temperatures, those reactions slow. Platelet function is also impaired by hypothermia. A VET run at 37°C may not fully reflect the degree of coagulation impairment present at the patient's actual body temperature.
- Even mild hypothermia (35–36°C) can measurably reduce clotting enzyme activity
- Platelet aggregation is impaired at temperatures below 36°C
- Standard VET runs at 37°C and may underestimate the functional deficit in the patient
- Active rewarming is part of the management, not a background task
Acidosis
A low pH reduces the activity of coagulation enzymes and impairs both factor complex function and platelet behavior. In major bleeding, acidosis is often driven by hypoperfusion and ongoing loss, which may worsen as bleeding continues.
- pH below 7.2 significantly impairs coagulation factor activity
- Acidosis can reduce the efficacy of coagulation factors even at normal concentrations
- Hypoperfusion and ongoing loss tend to worsen acidosis over time
- Treating the underlying cause (source control, restoring perfusion) matters alongside product administration
Low ionized calcium
Ionized calcium is required for several steps in the coagulation cascade and for platelet activation. Large volumes of blood products — particularly fresh frozen plasma and red cells containing citrate — can reduce ionized calcium. Calcium replacement is easily overlooked during rapid transfusion.
- Calcium is required for coagulation factor activity and platelet function
- Citrate in blood products binds ionized calcium and can lower its level rapidly
- Check ionized calcium during rapid transfusion and correct according to local protocol
- Do not assume normal total calcium reflects adequate ionized calcium
Dilution
Large-volume crystalloid, colloid, or cardiopulmonary bypass reduces the concentration of fibrinogen, coagulation factors, and platelets. When dilution is present, the apparent coagulation deficit may be partly a concentration problem. Understanding which components are limiting clot formation is more useful than replacing everything broadly.
- Crystalloid dilutes fibrinogen, factors, and platelets simultaneously
- CPB combines hemodilution, activation, and consumption
- Low fibrin-based clot firmness in the context of significant dilution may respond to targeted fibrinogen replacement
- Ongoing surgical bleeding continues to dilute the patient even after products are given
Ongoing bleeding continues to dilute
If surgical bleeding has not been controlled, resuscitation and product replacement may be partially offset by continued blood loss. Source control is part of the physiology — not a separate step after it.
An action frame
- Check temperature and begin active rewarming if below 36°C
- Check pH and assess whether hypoperfusion or ongoing loss is driving acidosis
- Check ionized calcium and correct according to local protocol during rapid transfusion
- Assess the degree of dilution from crystalloid, colloid, or CPB
- Correct physiology in parallel with targeted product replacement — not after
- Reassess the VET pattern and the actual bleeding after each intervention
- If bleeding persists after physiology and products are addressed, reassess the surgical field
- Follow institutional protocol and blood bank availability
Take-home message
Physiology correction and targeted product replacement run together, not in sequence. Hypothermia, acidosis, low calcium, and dilution each limit clot formation and should be assessed alongside every product decision.
Clinical content by Kozo Watanabe, MD View profile →
Verify your decision
After correcting physiology — reassess the VET pattern and the actual bleeding. Use the ROTEM trigger guide to interpret whether a residual coagulation deficit remains.
Open the ROTEM trigger guide →Continue learning
Surgical bleeding vs coagulopathy: the first split
Before treating perioperative bleeding as a coagulation problem, decide whether the bleeding pattern fits a surgical source, coagulopathy, or a mixed picture.
Fibrinogen first: when clot firmness is low
Low fibrin-based clot firmness can make diffuse bleeding difficult to control, but fibrinogen replacement should be interpreted as a targeted correction followed by reassessment — not an automatic order.
Heparin effect after CPB: do not confuse it with factor deficiency
A prolonged clotting time after CPB can reflect residual heparin, factor deficiency, dilution, hypothermia, sampling timing, or protamine effect. The clinical question is not simply “give more protamine.”